Centaurus faces quite an uphill battle from here, unfortunately. They wasted their $600K golden opportunity off an earlier PP with virtually no strings attached. Future financing will certainly be more stringent if not toxic. Furthermore, there really is not much of a company to speak of. They are strapped for cash, they don't own the Magnateks, and they've failed to execute repeatedly. It comes down to how much people value AS's patents and IP. The company, IMO, has little more to offer.